PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line
© Tsubata et al; licensee BioMed Central Ltd. 2005
Received: 20 July 2005
Accepted: 23 July 2005
Published: 23 July 2005
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia (ATL), whereas HTLV type 2 (HTLV-2), is not associated with ATL or any other leukemia. HTLV-1 encodes the transforming gene tax1, whose expression in an interleukin (IL)-2-dependent T-cell line (CTLL-2) induces IL-2-independent growth.
In this study, we demonstrated that IL-2-independent growth induction by Tax1 was abrogated by mutations of the PDZ domain-binding motif (PBM) at the Tax1 C-terminus. HTLV-2 Tax2, which shares 75% amino acid identity with Tax1 but does not have a PBM, was not able to induce IL-2-independent growth of CTLL-2.
Our results suggest that Tax1, through interaction with PDZ domain protein(s) induces IL-2-independent growth, which may be a factor in multi-step leukemogenesis caused by HTLV-1.
Adult T-cell leukemia (ATL) is an extremely aggressive T-cell leukemia [1, 2], and it is characterized by malignant expansion of CD4 positive T-cells infected with human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 is an onco-retrovirus, which immortalizes human CD4 T-cells in vitro [3, 4]. Such an immortalization event is, however, not sufficient for ATL development, since a minority of HTLV-1-infected individuals (~5%) suffer ATL 60 years on average after the infection [2, 5, 6]. Accumulating evidence suggests that genetic and epigenetic changes in HTLV-1-infected T-cells and deterioration of host immune activities are prerequisites for ATL development . HTLV type 2 (HTLV-2) is molecularly and biologically similar to HTLV-1 [7, 8]. HTLV-2 also immortalizes primary human T-cells with equivalent efficiency to HTLV-1, although HTLV-2 preferentially immortalizes CD8 T-cells . Regardless of such similarities, HTLV-2 is not associated with ATL or any other leukemia . Thus, HTLV-2 can not promote multi-step leukemogenesis. However, the underlying mechanism by which HTLV-1 promotes multi-step leukemogenesis has not yet been elucidated.
HTLV-1 and HTLV-2 encode functionally and structurally similar proteins, Tax1 and Tax2, respectively [7, 11, 12], and they are candidate factors responsible for distinct pathogenic activities of the two viruses. Tax1 and Tax2 were originally identified as transcriptional activators of their own gene expression [11, 12]. Later they were shown to play crucial roles in the immortalization of T-cells [13, 14]. Tax1 by itself immortalizes primary human T-cells in an interleukin (IL)-2-dependent manner [15, 16]. Tax1 inhibits several modes of apoptosis , and stimulates the cell cycle progression in primary T-cells as well as in T-cell lines [18, 19]. In addition, in transgenic animals Tax1 induces various malignancies such as fibrosarcoma and natural killer cell leukemia [20, 21]. Consistent with the above activities, recombinant HTLV-1 and HTLV-2 carrying inactive tax1 and tax2 genes, respectively, cannot transform primary human T-cells [13, 14]. Evidence suggests that the activation of cellular genes by Tax1 is essential for T-cell immortalization . For instance, Tax1 activates the expression of genes encoding cytokines, cytokine receptors, chemokines, cell cycle regulators and anti-apoptotic factors [22–31]. Tax1 and Tax2 generally activate the same sets of cellular genes with equivalent efficiency, although some differences have been reported.
Characterization of Tax1, Tax2B, and their mutants
IL-2 independent proliferation of CTLL-2
CFSA of Rat-1#
HTLV-1 Tax1 oncoprotein changes the cell growth of CTLL-2 from being IL-2-dependent to being IL-2-independent . In this study, we showed that the PBM of Tax1 is essential for this activity in CTLL-2. Unlike Tax1, HTLV-2 Tax2 did not induce IL-2-independent growth, consistent with the absence of PBM in Tax2. Taken together with the strict conservation of PBM only in HTLV-1 Tax1 , these results suggest that HTLV-1 and HTLV-2 infection have distinct activity to growth of infected T-cells, and such a difference may be a factor responsible for ATL development.
Tax1, but not Tax2, interacts with the PDZ domain containing proteins Dlg and MAGI-3 [33, 36]. Cotransfection and immunoprecipitation experiments showed that the three Tax1 mutants used here are severely defective in interaction with both Dlg and MAGI-3 proteins (Table 1). Dlg is highly expressed in T-cells including HTLV-1-infected T-cell lines [33, 35], whereas MAGI-3 was detected only by reverse-transcription polymerase chain reaction analysis . Since Dlg is a tumor suppressor gene product in Drosophila, it is an attractive candidate to play a role in IL-2-independent growth induction in CTLL-2 cells. It should be noted that there are many PDZ domain-containing genes in human. Thus, it is important to consider such proteins as candidates to mediate Tax1 activity in HTLV-1-infected T-cells.
We recently showed that Tax2, through the activation of transcription factor NFAT, constitutively induces the expression of IL-2, and the induced IL-2 promotes the cell growth of HTLV-2-infected T-cell lines, whereas such autocrine growth stimulation was not detected in HTLV-1-infected T-cell lines . Tax2, however, did not induce IL-2-independent growth of CTLL-2 cells. In addition to Tax2B, Tax2B+C also failed to induce IL-2-independent growth of CTLL-2 cells. Tax2B+C, but not Tax2, transforms Rat-1 cells (CFSA) to the same extent as Tax1, and interacts with Dlg and MAGI-3 (Table 1) [33, 36]. Thus, the binding of Tax2B+C to PDZ domain-containing proteins is not sufficient to induce IL-2-independent growth. Although it is unclear why we could not detect the activity of Tax2 to induce IL-2-independent growth, one possibility is that NFAT activation by Tax2 may induce the expression of pro-apoptotic genes such as Fas ligand, which may induce apoptosis of CTLL-2 cells, thereby masking the growth-promoting effect of IL-2.
Tax1 PBM plays crucial roles in the growth promoting activities in two different cell backgrounds; IL-2-independent growth induction of a T-cell line and transformation (CFSA) of a Rat-1 fibroblast cell line (Table 1), but it is unclear whether these two activities utilize the same mechanism. Both the number and size of the transformed colonies of Rat-1/Tax1 cells were greater than those of Rat-1/Tax2B cells, but the presence of Tax1 PBM was only correlated with the number but not the colony size . These results suggest that the Tax1 PBM may have a selective role in the initiation of anchorage-independent growth of Rat-1 cells in soft agar but not the subsequent growth speed. Similarly, Tax1 PBM might be required for the initial cell growth of CTLL-2 deprived from IL-2, but not the subsequent rate of growth. Further analysis is required to solve this interesting question.
Several tumor viruses have both high-risk and low-risk subtypes. High-risk viruses induce malignancies such as cancers or leukemia in the host, whereas low-risk viruses induce benign tumors or lymphoproliferative diseases. Human papilloma virus (HPV) is such a virus, and only high-risk subtypes are associated with cervical cancers. Interestingly, an E6 oncoprotein of high-risk HPVs also contains PBM, and the motif is associated with high level of transforming activities measured by CFSA or focus formation of fibroblast cell lines in vitro . Moreover, while E6 induces tumors in transgenic mice, deletion of the E6 PBM abrogates such activity . Thus, PBM is a common determinant for high-risk oncoviruses, thereby being a useful tool for elucidating the molecular mechanism of malignant conversion of virus-infected cells.
Several inhibitors of transcription factor NF-κB induced apoptosis in HTLV-1-infected T-cell lines . In addition, activation of NF-κB by Tax1 was well correlated with the induction of IL-2-independent growth of CTLL-2 . However, NF-κB does not account for cell death of CTLL-2/TaxΔC cells in the absence of IL-2, since TaxΔC has equivalent NF-κB activity to Tax1 . Taken together, the present results suggest that Tax1 PBM cooperates with NF-κB to induce IL-2-independent growth of HTLV-1-infected cells.
We thank William W Hall for donating the Tax2B plasmid and the antibody against Tax2B. We thank the Takeda pharmaceutical company for providing recombinant human IL-2. We also thank Sayoko Takizawa and Chika Yamamoto for the excellent technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas and a Grant-in-Aid for Scientific Research (C) of Japan and a Grant for Promotion of Niigata University Research Projects.
- Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977, 50: 481-492.PubMedGoogle Scholar
- Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003, 22: 5131-5140. 10.1038/sj.onc.1206551.View ArticlePubMedGoogle Scholar
- Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981, 294: 770-771. 10.1038/294770a0.View ArticlePubMedGoogle Scholar
- Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y: Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science. 1982, 217: 737-739.View ArticlePubMedGoogle Scholar
- Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980, 77: 7415-7419.PubMed CentralView ArticlePubMedGoogle Scholar
- Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I: Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981, 78: 6476-6480.PubMed CentralView ArticlePubMedGoogle Scholar
- Seiki M, Hattori S, Hirayama Y, Yoshida M: Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983, 80: 3618-3622.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen IS, McLaughlin J, Gasson JC, Clark SC, Golde DW: Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature. 1983, 305: 502-505. 10.1038/305502a0.View ArticlePubMedGoogle Scholar
- Chen IS, Quan SG, Golde DW: Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A. 1983, 80: 7006-7009.PubMed CentralView ArticlePubMedGoogle Scholar
- Sugamura K, Hinuma Y: Human retroviruses:HTLV-I and HTLV-II. The Retroviridae. Edited by: Levy JA. 1993, New York: Plenum Press, 2: 399-435.View ArticleGoogle Scholar
- Chen IS, Slamon DJ, Rosenblatt JD, Shah NP, Quan SG, Wachsman W: The x gene is essential for HTLV replication. Science. 1985, 229: 54-58.View ArticlePubMedGoogle Scholar
- Seiki M, Hattori S, Hirayama Y, Yoshida M: Direct evidence that p40x of human T-cell leukemia virus type I is a trans- acting transcriptional activator. EMBO J. 1986, 5: 561-565.PubMed CentralPubMedGoogle Scholar
- Ross TM, Pettiford SM, Green PL: The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol. 1996, 70: 5194-5202.PubMed CentralPubMedGoogle Scholar
- Robek MD, Ratner L: Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol. 1999, 73: 4856-4865.PubMed CentralPubMedGoogle Scholar
- Akagi T, Shimotohno K: Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J Virol. 1993, 67: 1211-1217.PubMed CentralPubMedGoogle Scholar
- Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U: Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol. 1992, 66: 4570-4575.PubMed CentralPubMedGoogle Scholar
- Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, Heeney JL: Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses. 1994, 10: 1259-1268.View ArticlePubMedGoogle Scholar
- Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT, Comb MJ: Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J Virol. 1997, 71: 1956-1962.PubMed CentralPubMedGoogle Scholar
- Ohtani K, Iwanaga R, Arai M, Huang Y, Matsumura Y, Nakamura M: Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. J Biol Chem. 2000, 275: 11154-11163. 10.1074/jbc.275.15.11154.View ArticlePubMedGoogle Scholar
- Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G: The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science. 1987, 237: 1324-1329.View ArticlePubMedGoogle Scholar
- Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L: Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995, 92: 1057-1061.PubMed CentralView ArticlePubMedGoogle Scholar
- Azran I, Schavinsky-Khrapunsky Y, Aboud M: Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology. 2004, 1: 20-10.1186/1742-4690-1-20.PubMed CentralView ArticlePubMedGoogle Scholar
- Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M: Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J. 1986, 5: 2883-2888.PubMed CentralPubMedGoogle Scholar
- Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC: HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science. 1988, 241: 1652-1655.View ArticlePubMedGoogle Scholar
- Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ: Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 1987, 49: 47-56. 10.1016/0092-8674(87)90754-9.View ArticlePubMedGoogle Scholar
- Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T: Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell. 1987, 48: 343-350. 10.1016/0092-8674(87)90437-5.View ArticlePubMedGoogle Scholar
- Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G, Iwanaga Y, Yamamoto N, Ohtani K, Nakamura M, Fujii M: Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol. 1999, 73: 7981-7987.PubMed CentralPubMedGoogle Scholar
- Akagi T, Ono H, Shimotohno K: Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene. 1996, 12: 1645-1652.PubMedGoogle Scholar
- Mori N, Fujii M, Hinz M, Nakayama K, Yamada Y, Ikeda S, Yamasaki Y, Kashanchi F, Tanaka Y, Tomonaga M, Yamamoto N: Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells. Int J Cancer. 2002, 99: 378-385. 10.1002/ijc.10388.View ArticlePubMedGoogle Scholar
- Iwanaga R, Ohtani K, Hayashi T, Nakamura M: Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 2001, 20: 2055-2067. 10.1038/sj.onc.1204304.View ArticlePubMedGoogle Scholar
- Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M: HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene. 1991, 6: 1023-1029.PubMedGoogle Scholar
- Endo K, Hirata A, Iwai K, Sakurai M, Fukushi M, Oie M, Higuchi M, Hall WW, Gejyo F, Fujii M: Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J Virol. 2002, 76: 2648-2653. 10.1128/JVI.76.6.2648-2653.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Hirata A, Higuchi M, Niinuma A, Ohashi M, Fukushi M, Oie M, Akiyama M, Tanaka Y, Gejyo F, Fujii M: PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein augments the transforming activity in a rat fibroblast cell line. Virology. 2004, 318: 327-336. 10.1016/j.virol.2003.10.006.View ArticlePubMedGoogle Scholar
- Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P: The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene. 1998, 16: 643-654. 10.1038/sj.onc.1201567.View ArticlePubMedGoogle Scholar
- Suzuki T, Ohsugi Y, Uchida-Toita M, Akiyama T, Yoshida M: Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control. Oncogene. 1999, 18: 5967-5972. 10.1038/sj.onc.1203008.View ArticlePubMedGoogle Scholar
- Ohashi M, Sakurai M, Higuchi M, Mori N, Fukushi M, Oie M, Coffey RJ, Yoshiura K, Tanaka Y, Uchiyama M, Hatanaka M, Fujii M: Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3. Virology. 2004, 320: 52-62. 10.1016/j.virol.2003.11.014.View ArticlePubMedGoogle Scholar
- Iwanaga Y, Tsukahara T, Ohashi T, Tanaka Y, Arai1 M, Nakamura M, Ohtani K, Koya Y, Kannagi M, Yamamoto N, Fujii M: Human T-cell leukemia virus type 1 Tax protein abrogates interleukin 2 dependence in a mouse T-cell line. J Virol. 1999, 73: 1271-1277.PubMed CentralPubMedGoogle Scholar
- Niinuma A, Higuchi M, Takahashi M, Oie M, Tanaka Y, Gejyo F, Tanaka N, Sugamura K, Xie L, Green PL, Fujii M: Aberrant Activation of the Interleukin 2 Autocrine Loop through NFAT by Non-leukemogenic Human T-cell Leukemia Virus Type 2 but not Leukemogenic Type 1 Virus. J Virol.Google Scholar
- Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M: Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A. 1997, 94: 11612-11616. 10.1073/pnas.94.21.11612.PubMed CentralView ArticlePubMedGoogle Scholar
- Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF: The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol. 2003, 77: 6957-6964. 10.1128/JVI.77.12.6957-6964.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M: Bay 11–7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood. 2002, 100: 1828-1834. 10.1182/blood-2002-01-0151.View ArticlePubMedGoogle Scholar
- Tanaka Y, Yoshida A, Tozawa H, Shida H, Nyunoya H, Shimotohno K: Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer. 1991, 48: 623-630.View ArticlePubMedGoogle Scholar
- Lewis MJ, Novoa P, Ishak R, Ishak M, Salemi M, Vandamme AM, Kaplan MH, Hall WW: Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II). Virology. 2000, 271: 142-154. 10.1006/viro.2000.0284.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.